top of page

VitaFoods Europe 2024 Deep Dive: ILDONG Bioscience's Breakthroughs in Postbiotics- Day 2

Welcome to Day 2 of our adventure at VitaFoods Europe 2024! Today was a showcase of how traditional ingredients are being transformed by innovative science, especially in the realm of postbiotics. ILDONG Bioscience is at the forefront of these developments, and we're excited to share the insights and highlights from an engaging day at the show.

The Rising Interest in Postbiotics

Postbiotics are gaining traction in the nutraceutical industry due to their robust health benefits and stability compared to live probiotics. These bioactive compounds, which are non-living byproducts from probiotic bacteria, have shown great promise in supporting immune health and managing cholesterol levels.


Today, we showcased two of our pioneering postbiotic products, BBR4401 and RHT3201, which are at the forefront of these health benefits. Let's dive into the details of these products and their innovative applications.


BBR4401: Pioneering Cholesterol Management

Our BBR4401 is a groundbreaking postbiotic aimed at tackling high LDL cholesterol, a common concern for many. BBR4401 has undergone extensive research to prove its efficacy in reducing cholesterol absorption and enhancing its elimination from the body.


Functionality and Benefits of BBR4401

  • Effective Cholesterol Management: BBR4401 interacts with the gut flora to modify the metabolism of cholesterol. By limiting the absorption of cholesterol in the gut and facilitating its removal, BBR4401 supports the maintenance of healthy cholesterol levels, which is crucial for cardiovascular health.

  • Research-Backed Results: Clinical studies highlighted on our webpage demonstrate BBR4401's ability to significantly lower LDL cholesterol levels without the side effects commonly associated with pharmaceutical treatments. This makes BBR4401 an ideal supplement for those seeking natural methods to manage their cholesterol.


Innovative Application: BBR4401 in Syrup Form

At today's event, we were excited to share how one of our European customers has successfully integrated BBR4401 into a syrup application. This innovative approach not only simplifies the process of cholesterol management but also makes it more appealing and accessible to a broader audience.

  • Syrup Application: The syrup, enhanced with BBR4401, offers a consumer-friendly option for incorporating this postbiotic into daily routines. This format is especially appealing to those who prefer not to take capsules or tablets.

  • Taste and Compliance: By incorporating BBR4401 into a syrup, we've managed to maintain the efficacy of the postbiotic while improving the taste and overall user experience, which is key to ensuring long-term compliance and effectiveness.


RHT3201: Boosting Immune Health

RHT3201® is a postbiotic developed by ILDONG Bioscience, approved by Korea's FDA for its immune-balancing properties. Clinically proven to reduce hypersensitivity and alleviate symptoms of atopic dermatitis, RHT3201® uses Lactobacillus rhamnosus IDCC 3201 tyndallizate. It shows significant improvements in symptoms and decreases inflammatory markers such as eosinophil count and IL-31 levels. RHT3201® is especially effective in long-term cases and has a strong safety profile, offering a promising solution for managing immune-related conditions.


Functionality and Benefits of RHT3201

  • Immune Balancing: Helps regulate immune responses.

  • Reduction of Hypersensitivity: Decreases symptoms related to hypersensitivity reactions.

  • Improvement in Atopic Dermatitis: Clinically proven to alleviate symptoms of atopic dermatitis.

  • Reduction of Inflammatory Markers: Lowers eosinophil count and IL-31 levels.

  • Safety and Efficacy: Demonstrates a strong safety profile and efficacy, especially in long-term use.


Reflecting on a Productive Day

We’re energized by the enthusiasm and engagement from everyone who joined us. The interest in postbiotics and their application in health products shows a promising direction for the industry and for ILDONG Bioscience.


We look forward to continuing our journey at VitaFoods Europe 2024, sharing more about our innovations, and learning from our peers. Stay tuned for more updates as we continue to explore the dynamic world of nutraceuticals and pave the way for healthier futures.

Comments


bottom of page